Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.5650
+0.0100 (1.80%)
Aug 28, 2026, 4:10 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 191.98 million as of August 28, 2026. Its market cap has decreased by -12.38% in one year.
Market Cap
191.98M
Enterprise Value
174.69M
Revenue
86.47M
Ranking
n/a
PE Ratio
51.68
Stock Price
0.57
ChartMarket Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 191.98M, a decrease of -52.61%. That is a compound annual growth rate of -11.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 191.98M | -24.81% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 711.57M |
| Imricor Medical Systems | 692.04M |
| EBR Systems | 222.24M |
| EMVision Medical Devices | 160.35M |
| Saluda Medical | 156.25M |
| Lumos Diagnostics Holdings | 99.16M |
| Epiminder | 77.89M |
| SomnoMed | 72.30M |